Skip to main content
. 2023 Jan 24;16:6. doi: 10.1186/s13045-023-01398-5

Fig. 3.

Fig. 3

Protein degradation modulates drug metabolism. Drug metabolism can be categorized into Phase I (oxidation, reduction, and hydrolysis) and Phase II (posttranslational modification), requiring different classes of drug metabolic enzymes. In Phase I drug metabolism, CHIP and AMFR can ubiquitinate the CYP3A family for degradation. In Phase II, SULT1A3 is regulated by ubiquitin-dependent protein degradation